Prenatal Diagnostics Market – Interviews, Company Goals and Customer Feedback Analyzed


Posted November 27, 2015 by scottlisa57

This report includes specifications of particular instruments, exclusive interviews with CEOs, CSOs, and Vice Presidents of the participating companies.

 
Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with Prenatal Diagnostics market in subject line and your contact details.
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor. This report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare. Although covering standard invasive procedure, this report focuses on the noninvasive technologies either on the market or in development.

Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=274703
Single User License: US $2495;
Report Highlights:
• Exclusive interviews with CEOs, CSOs, and Vice Presidents from Sequenom, Verinata Health, Ariosa Diagnostics, Natera, Silicon Biosystems, Metabolomic Diagnostics and NX PharmaGen
• Specifications of particular instruments
• Company goals, customer feedback, challenges encountered, competitive advantage, platform pricing, and future endeavors.
• A survey capturing the demographics of the prenatal industry is presented at the end of the report, specifically highlighting organizational background, areas of research, challenges encountered, and applications in development.
• Directory of companies within Prenatal Diagnostics
Executive Summary
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor. This report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare. Although covering standard invasive procedure, this report focuses on the noninvasive technologies either on the market or in development.


The first chapter of this report discusses microarray-based cytogenetics and how it compares to karyotyping. Karyotyping is often the standard method used to detect chromosomal aneuploidies, but with microarray-based procedures even more aneuploidies can be detected with the same efficacy. Either method can be used in sync with noninvasive procedures that show positive screening results for aneuploidies, but microarray analysis may be more useful for copy number variations that often go undetected with karyotyping.

Buy a copy of report @ [url=http://www.reportsnreports.com/Purchase.aspx?name=274703]http://www.reportsnreports.com/Purchase.aspx?name=274703[/url]
Single User License: US $2495;

Highlighting noninvasive methods, several companies have come out with novel technologies that allow them to analyze fetal DNA without risk of injury to the mother or fetus. Amniocentesis and chorionic villus sampling are common methods used to analyze fetal DNA for aneuploidies but at the risk of miscarriage and infection. With noninvasive procedures, screening can be done for common aneuploidies and further analysis can be done on women with only positive results. This not only decreases the amount of unnecessary invasive testing but also the amount of unnecessary stress levels of many expecting mothers. Companies participating in this section include:
• Sequenom
• Verinata Health
• Ariosa Diagnostics
• Natera
• Silicon Biosystems
Other areas discussed in this report include preeclampsia and preterm labor. Preeclampsia is a common condition in women and often isn't detected until later in pregnancy. It can lead to preterm labor, which may be fatal for both the fetus and the mother. So far, a test to screen for the likelihood of preeclampsia does not exist. Detecting the risk of preeclampsia early in pregnancy can allow the expecting mother to take necessary action to avoid preterm labor at all costs, decreasing any complications that may severely affect the fetus including death. Companies highlighted in this section include:
• Metabolomic Diagnostics
• NX PharmaGen



In addition to covering several aspects of prenatal diagnostics, this report also includes specifications of particular instruments, exclusive interviews with CEOs, CSOs, and Vice Presidents of the participating companies. Specific areas of focus include company goals, customer feedback, challenges encountered, competitive advantage, platform pricing, and future endeavors. A survey capturing the demographics of the prenatal industry is presented at the end of the report, specifically highlighting organizational background, areas of research, challenges encountered, and applications in development.
Table of Contents
Executive Summary
Part I: Prenatal Applications
Part III: Prenatal Complications
Part IV: Demographic Survey
Part V: Company Directory: A list of companies working in Prenatal Diagnostics

Inquiry Before Buying @ [url=http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=274703/]http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=274703[/url]

List Tables
Table 3.1: MaterniT21 PLUS aneuploidy performance
Table 3.2: MaterniT21 PLUS
Table 4.1: verifi prenatal test performance for aneuploidies
Table 4.2: verifi prenatal test performance for sex chromosomes
Table 4.3: verifi prenatal test
Table 5.1 Harmony Test
Table 6.1: Panorama Test
Table 7.1: DEPArray System
Table 8.1: Noninvasive screening test specifications




List of Figures
Figure 12.1: Survey demographics
Figure 12.2: Screening vs. testing
Figure 12.3: Specific areas of research
Figure 12.4: Challenges encountered
Figure 12.5: Preferred applications of use
Figure 12.6: Competitive strategies

Browse All Reports on Healthcare Market.

Contact [email protected] / Call +1 888 391 5441 for further information on “Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor ” report OR for any other market research and intelligence needs you may have for your business.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Lisa
Country India
Categories Business
Last Updated November 27, 2015